Among 15 analysts covering Amedisys Inc. (NASDAQ:AMED), 7 have Buy rating, 0 Sell and 8 Hold. Therefore 47% are positive. Amedisys Inc. had 37 analyst reports since September 1, 2015 according to SRatingsIntel. The company was maintained on Thursday, November 9 by Craig Hallum. The rating was upgraded by Mizuho on Monday, November 7 to “Buy”. The stock of Amedisys, Inc. (NASDAQ:AMED) earned “Neutral” rating by Robert W. Baird on Wednesday, January 13. The rating was maintained by RBC Capital Markets with “Hold” on Thursday, November 9. The stock of Amedisys, Inc. (NASDAQ:AMED) has “Buy” rating given on Tuesday, January 23 by William Blair. The stock of Amedisys, Inc. (NASDAQ:AMED) earned “Equal-Weight” rating by Stephens on Friday, June 17. The company was downgraded on Thursday, November 9 by Benchmark. The firm has “Buy” rating given on Wednesday, June 7 by Jefferies. The stock of Amedisys, Inc. (NASDAQ:AMED) earned “Neutral” rating by Mizuho on Wednesday, March 1. RBC Capital Markets maintained the stock with “Hold” rating in Sunday, October 22 report. See Amedisys, Inc. (NASDAQ:AMED) latest ratings:
23/01/2018 Broker: William Blair Rating: Buy Maintain
10/11/2017 Broker: Robert W. Baird Rating: Neutral Old Target: $50 New Target: $60 Maintain
09/11/2017 Broker: Craig Hallum Rating: Buy New Target: $68.0 Maintain
09/11/2017 Broker: RBC Capital Markets Rating: Hold New Target: $62.0 Maintain
09/11/2017 Broker: Benchmark Old Rating: Buy New Rating: Hold Downgrade
08/11/2017 Broker: Mizuho Rating: Buy New Target: $65.0 Maintain
05/11/2017 Broker: Robert W. Baird Rating: Hold New Target: $50.0 Maintain
02/11/2017 Broker: Mizuho Old Rating: Neutral New Rating: Buy Upgrade
02/11/2017 Broker: Benchmark Old Rating: Hold New Rating: Buy Old Target: $50 Upgrade
22/10/2017 Broker: RBC Capital Markets Rating: Hold New Target: $56.0 Maintain
Granite Investment Partners Llc decreased Landec Corp (LNDC) stake by 34.33% reported in 2017Q3 SEC filing. Granite Investment Partners Llc sold 63,416 shares as Landec Corp (LNDC)’s stock declined 1.12%. The Granite Investment Partners Llc holds 121,329 shares with $1.57 million value, down from 184,745 last quarter. Landec Corp now has $360.69M valuation. It closed at $13.1 lastly. It is down 17.05% since February 4, 2017 and is uptrending. It has outperformed by 0.35% the S&P500.
Investors sentiment decreased to 1.71 in 2017 Q3. Its down 0.04, from 1.75 in 2017Q2. It worsened, as 26 investors sold Amedisys, Inc. shares while 29 reduced holdings. 30 funds opened positions while 64 raised stakes. 31.75 million shares or 5.19% more from 30.18 million shares in 2017Q2 were reported. D E Shaw & Inc owns 503,366 shares. Tygh Capital Mngmt Inc has invested 0.6% of its portfolio in Amedisys, Inc. (NASDAQ:AMED). Security Com stated it has 1,000 shares. 16,654 are owned by Sterling Mgmt Lc. Ahl Ltd Liability Partnership stated it has 110,022 shares or 0.11% of all its holdings. Teachers Retirement System Of The State Of Kentucky reported 11,167 shares or 0.01% of all its holdings. Louisiana State Employees Retirement System accumulated 11,500 shares. Riggs Asset Managment Co reported 450 shares. Columbia Wanger Asset Management Limited Liability Corp holds 0.07% or 84,466 shares. Timessquare Capital Ltd Llc has invested 0.23% in Amedisys, Inc. (NASDAQ:AMED). Hancock Holdings Company holds 0.3% or 126,910 shares in its portfolio. Ontario – Canada-based Manufacturers Life Insur The has invested 0% in Amedisys, Inc. (NASDAQ:AMED). Massachusetts-based State Street has invested 0% in Amedisys, Inc. (NASDAQ:AMED). Sector Pension Invest Board, a Quebec – Canada-based fund reported 17,687 shares. 612,689 were accumulated by Millennium Management Ltd Liability.
The stock decreased 1.80% or $0.94 during the last trading session, reaching $51.42. About 268,957 shares traded. Amedisys, Inc. (NASDAQ:AMED) has risen 15.02% since February 4, 2017 and is uptrending. It has underperformed by 1.68% the S&P500.
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. The company has market cap of $1.75 billion. It operates through three divisions: Home Health, Hospice, and Personal Care. It has a 40.78 P/E ratio. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses, physical and speech therapists, occupational therapists, and aides for its patients to complete their important personal tasks.
Among 4 analysts covering Landec (NASDAQ:LNDC), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. Landec had 7 analyst reports since November 18, 2015 according to SRatingsIntel. Wedbush initiated Landec Corporation (NASDAQ:LNDC) on Friday, July 8 with “Neutral” rating. As per Tuesday, June 7, the company rating was initiated by Maxim Group. The firm has “Buy” rating by Maxim Group given on Tuesday, July 18. The rating was maintained by Wedbush with “Hold” on Wednesday, July 26. Maxim Group maintained it with “Buy” rating and $1800 target in Wednesday, July 26 report. Wunderlich initiated it with “Buy” rating and $18 target in Wednesday, November 18 report. Sidoti upgraded the stock to “Buy” rating in Monday, January 25 report.
Since October 23, 2017, it had 0 insider purchases, and 1 insider sale for $96,659 activity. The insider Hemmeter Molly sold 7,399 shares worth $96,659.